Why VCs are suddenly obsessed with women’s health

Over the next two decades, roughly $124 trillion is expected to change hands in what analysts describe as the largest intergenerational wealth transfer in history. A growing share of that wealth is moving to women through inheritance, entrepreneurship, and rising lifetime earnings. At the same time, healthcare is confronting another reality: Much of modern medicine was built around male biology. Those two shifts are beginning to collide. For decades, women were routinely excluded from clinical trials. In the United States, women were not required to be included in federally funded studies until 1993. Drug dosing, symptom recognition, diagnostic frameworks, and even many medical AI systems were largely built around male biological baselines. The consequences were not small. In 2013, the FDA cut the recommended dose of zolpidem, a widely prescribed sleep medication under the Ambien brand name, after data showed women metabolized the drug differently than men. Women were waking up with higher levels of the drug still in their bloodstream, increasing the risk of car accidents and falls the next morning. The drug had been approved in 1992. The risk existed for decades. It simply had not been properly measured. A market problem But this was not just a healthcare problem. It was also a market problem. When conditions affecting women were poorly studied or misunderstood, they were often treated as quality-of-life issues instead of major economic and healthcare issues. That shaped where research dollars went, where venture capital flowed, and which companies received serious attention. In other words, large parts of women’s health were systematically undervalued. That mispricing influenced everything from product development to investment decisions. Investors tend to fund markets they can clearly measure and model. But when women’s symptoms were historically underdiagnosed or dismissed, the size of the opportunity remained hidden inside incomplete data. This helps explain wh